Pictet Asset Management
XBI icon

Pictet Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pictet Asset Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,854
Closed -$365K – 2210
2026
Q1 		$365K Sell
2,854
-2,631
-48% -$328K ﹤0.01% 1629
2025
Q4 		$669K Buy
+5,485
New +$629K ﹤0.01% 1296

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

Pictet Asset Management's XBI Position: Q2 2026 in Review

Pictet Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 2,854 shares — an estimated $365K sold.

Pictet Asset Management first reported a position in XBI in Q4 2025 and held it in 2 quarters. The position peaked at $669K in Q4 2025. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Pictet Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Pictet Asset Management sold 2,854 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $365K.
  • Pictet Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and held it in 2 quarters.
  • Pictet Asset Management's State Street SPDR S&P Biotech ETF position peaked at $669K in Q4 2025.
  • 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.